Durable Medical Equipment Market Size, Share, Trends, Industry Analysis Report By Product (Personal Mobility Device, Bathroom Safety Device, Medical Furniture), By End Use, By Region – Market Forecast, 2025–2034
Description
The durable medical equipment market size is expected to reach USD 414.05 billion by 2034, according to a new study by Polaris Market Research. The report “Durable Medical Equipment Market Size, Share, Trends, Industry Analysis Report By Product (Personal Mobility Device, Bathroom Safety Device, Medical Furniture), By End Use, By Region– Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Durable medical equipment refers to medically necessary devices designed for long-term use to aid patients in their daily activities or treatment at home or in healthcare settings. These include items such as wheelchairs, hospital beds, walkers, oxygen equipment, and blood sugar monitors.
Governments and private insurers in many countries are expanding coverage for durable medical equipment. When insurance covers the cost, patients are more likely to get the equipment they need without financial strain. Reimbursement policies make DME more accessible, especially for expensive devices such as electric wheelchairs or hospital beds. These supportive policies increase consumer confidence and drive sales. In the U.S., for example, Medicare and Medicaid provide significant DME coverage, which encourages market growth. The market will continue to benefit from policy support as more insurers recognize the importance of DME in preventive care and recover.
Many countries are investing in building and upgrading healthcare facilities due to growing healthcare needs. This includes more hospitals, rehabilitation centers, and elder care homes, all of which require a steady supply of durable medical equipment. Healthcare providers are also seeking better quality and more reliable equipment to improve patient care and operational efficiency. Access to care is expanding in rural and underserved areas with better infrastructure, increasing demand for DME. This growth in healthcare infrastructure ensures consistent and large-scale purchases of medical equipment, contributing significantly to the overall durable medical equipment market expansion.
Durable Medical Equipment Market Report Highlights
In 2024, the monitoring and therapeutic devices segment held the largest market share, as products such as infusion pumps, CPAP machines, and patient monitors are vital for managing both chronic and acute health conditions.
The ambulatory surgical centers segment is expected to witness strong growth during 2025–2034, due to increasing demand for affordable and efficient outpatient procedures such as minimally invasive surgeries.
North America led the market in 2024 with a 38% revenue share, supported by a growing aging population and a high incidence of chronic diseases such as diabetes and heart disease.
The Asia Pacific market is anticipated to experience significant growth during the forecast period, driven by advancements in healthcare infrastructure and greater awareness of chronic disease management.
A few global key players in the durable medical equipment market are ArjoHuntleigh; Becton, Dickinson and Company; Carex Health Brands; GF Health Products Inc.; Hill-Rom; Invacare Corporation; Medline Industries, Inc.; Medtronic PLC; Stryker; and Sunrise Medical.
Polaris Market Research has segmented the durable medical equipment market report based on product, end use, and region:
By Product (Revenue - USD Billion, 2020–2034)
Personal Mobility Devices
Wheelchairs
Scooters
Walker and Rollators
Cranes and Crutches
Door Openers
Other Devices
Bathroom Safety Devices & Medical Furniture
Commodes and Toilets
Mattress & Bedding Devices
Monitoring & Therapeutic Devices
Blood Sugar Monitors
Continuous Passive Motion (CPM)
Infusion Pumps Market
Nebulizers
Oxygen Equipment
Continuous Positive Airway Pressure (CPAP)
Suction Pumps
Traction Equipment
Other Equipment
Insulin Pumps
Ostomy Bags & Accessories
Other
Others
By End Use (Revenue - USD Billion, 2020–2034)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Home Healthcare
Skilled Nursing Facilities
Others
By Regional Outlook (Revenue - USD Billion, 2020–2034)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Durable medical equipment refers to medically necessary devices designed for long-term use to aid patients in their daily activities or treatment at home or in healthcare settings. These include items such as wheelchairs, hospital beds, walkers, oxygen equipment, and blood sugar monitors.
Governments and private insurers in many countries are expanding coverage for durable medical equipment. When insurance covers the cost, patients are more likely to get the equipment they need without financial strain. Reimbursement policies make DME more accessible, especially for expensive devices such as electric wheelchairs or hospital beds. These supportive policies increase consumer confidence and drive sales. In the U.S., for example, Medicare and Medicaid provide significant DME coverage, which encourages market growth. The market will continue to benefit from policy support as more insurers recognize the importance of DME in preventive care and recover.
Many countries are investing in building and upgrading healthcare facilities due to growing healthcare needs. This includes more hospitals, rehabilitation centers, and elder care homes, all of which require a steady supply of durable medical equipment. Healthcare providers are also seeking better quality and more reliable equipment to improve patient care and operational efficiency. Access to care is expanding in rural and underserved areas with better infrastructure, increasing demand for DME. This growth in healthcare infrastructure ensures consistent and large-scale purchases of medical equipment, contributing significantly to the overall durable medical equipment market expansion.
Durable Medical Equipment Market Report Highlights
In 2024, the monitoring and therapeutic devices segment held the largest market share, as products such as infusion pumps, CPAP machines, and patient monitors are vital for managing both chronic and acute health conditions.
The ambulatory surgical centers segment is expected to witness strong growth during 2025–2034, due to increasing demand for affordable and efficient outpatient procedures such as minimally invasive surgeries.
North America led the market in 2024 with a 38% revenue share, supported by a growing aging population and a high incidence of chronic diseases such as diabetes and heart disease.
The Asia Pacific market is anticipated to experience significant growth during the forecast period, driven by advancements in healthcare infrastructure and greater awareness of chronic disease management.
A few global key players in the durable medical equipment market are ArjoHuntleigh; Becton, Dickinson and Company; Carex Health Brands; GF Health Products Inc.; Hill-Rom; Invacare Corporation; Medline Industries, Inc.; Medtronic PLC; Stryker; and Sunrise Medical.
Polaris Market Research has segmented the durable medical equipment market report based on product, end use, and region:
By Product (Revenue - USD Billion, 2020–2034)
Personal Mobility Devices
Wheelchairs
Scooters
Walker and Rollators
Cranes and Crutches
Door Openers
Other Devices
Bathroom Safety Devices & Medical Furniture
Commodes and Toilets
Mattress & Bedding Devices
Monitoring & Therapeutic Devices
Blood Sugar Monitors
Continuous Passive Motion (CPM)
Infusion Pumps Market
Nebulizers
Oxygen Equipment
Continuous Positive Airway Pressure (CPAP)
Suction Pumps
Traction Equipment
Other Equipment
Insulin Pumps
Ostomy Bags & Accessories
Other
Others
By End Use (Revenue - USD Billion, 2020–2034)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Home Healthcare
Skilled Nursing Facilities
Others
By Regional Outlook (Revenue - USD Billion, 2020–2034)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
125 Pages
- Chapter 1.Introduction
- 1.1Report Description
- 1.1.1Objectives of the Study
- 1.1.2Market Scope
- 1.1.3Assumptions
- 1.2Stakeholders
- Chapter 2.Executive Summary
- Chapter 3.Research Methodology
- 3.1Overview
- 3.1.1Data Mining
- 3.2Data Sources
- 3.2.1Primary Sources
- 3.2.2Secondary Sources
- Chapter 4.CRISPR & Cas Genes Market Insights
- 4.1CRISPR & Cas Genes – Industry snapshot
- 4.1CRISPR & Cas Genes Market Dynamics
- 4.1.1Drivers and Opportunities
- 4.1.1.1Innovations in CRISPR technologies
- 4.1.1.2Applicability in varied areas
- 4.1.2Restraints and Challenges
- 4.1.2.1Inherent Disadvantages
- 4.2Porter’s Five Forces Analysis
- 4.2.1Bargaining Power of Suppliers (Moderate)
- 4.2.2Threats of New Entrants: (Low)
- 4.2.3Bargaining Power of Buyers (Low to Medium)
- 4.2.4Threat of Substitute (Low)
- 4.2.5Rivalry among existing firms (Medium to High)
- 4.3PEST Analysis
- 4.4CRISPR & Cas Genes Market Industry trends
- 4.5COVID-19 Impact Analysis
- Chapter 5.Contact Point Information
- 5.1Contact Point Information for obtaining a license to use the technology
- 5.1.1Wellcome Trust Sanger Institute, Cambridge, UK
- 5.1.2The Innovative Genomics Initiative, California
- 5.1.3Thermo Fisher Scientific, Waltham, Massachusetts
- 5.1.4the Broad Institute and Whitehead Institute
- 5.1.5ERS Genomics Ltd
- 5.1.6Merck KGaA
- 5.1.7Oxford Genetics Limited
- 5.1.8Caribou Biosciences, Inc.
- 5.1.9CRISPR Therapeutics
- 5.1.10Sherlock Biosciences
- 5.1.11UC Berkeley
- 5.2The contract amount for genome editing technology
- Chapter 6.CRISPR & Cas Genes Market Assessment by Product & Services
- 6.1Introduction
- 6.2Product
- 6.2.1Kits & Enzymes
- 6.2.1.1Vector-based Cas
- 6.2.1.2DNA-free Cas
- 6.2.2Libraries
- 6.2.3Design Tool
- 6.2.5Other Products
- 6.3Services
- 6.3.1Cell Line Engineering
- 6.3.2gRNA Design
- 6.3.3Microbial Gene Editing
- 6.3.4DNA Synthesis
- Chapter 7.CRISPR & Cas Genes Market Assessment by Application
- 7.1Introduction
- 7.2Biomedical
- 7.3Agricultural
- Chapter 8.CRISPR & Cas Genes Market Assessment by End-Use
- 8.1Introduction
- 8.2Biotechnology & Pharmaceutical Companies
- 8.3Academics & Government Research Institutes
- 8.4Contract Research Organizations (CROs)
- Chapter 9.CRISPR & Cas Genes Market Assessment by Region
- 9.1Introduction
- 9.2CRISPR & Cas Genes Market – North America
- 9.2.1CRISPR & Cas Genes Market – U.S.
- 9.2.2CRISPR & Cas Genes Market – Canada
- 9.3CRISPR & Cas Genes Market – Europe
- 9.3.1CRISPR & Cas Genes Market – Germany
- 9.3.2CRISPR & Cas Genes Market – UK
- 9.3.3CRISPR & Cas Genes Market – France
- 9.3.4CRISPR & Cas Genes Market – Italy
- 9.3.5CRISPR & Cas Genes Market – Spain
- 9.3.6CRISPR & Cas Genes Market – Netherlands
- 9.3.7CRISPR & Cas Genes Market – Austria
- 9.4CRISPR & Cas Genes Market – Asia Pacific
- 9.4.1CRISPR & Cas Genes Market – China
- 9.4.2CRISPR & Cas Genes Market – India
- 9.4.3CRISPR & Cas Genes Market – Japan
- 9.4.4CRISPR & Cas Genes Market – South Korea
- 9.5CRISPR & Cas Genes Market – Latin America
- 9.5.1CRISPR & Cas Genes Market – Brazil
- 9.5.2CRISPR & Cas Genes Market – Mexico
- 9.5.3CRISPR & Cas Genes Market – Argentina
- 9.6CRISPR & Cas Genes Market – Middle East & Africa
- 9.6.1CRISPR & Cas Genes Market – Saudi Arabia
- 9.6.2CRISPR & Cas Genes Market – UAE
- Chapter 10.Competitive Landscape
- 10.1Product Launch & Collaborations Both Are The Best Adopted Strategies by the Companies
- 10.2Product Launch
- 10.3Partnerships/Collaborations/Agreements/Exhibitions
- Chapter 11.The Company Profiles
- 11.1Addgene
- 11.1.1Business Overview
- 11.1.2Financial Snapshot
- 11.1.3Products and Services
- 11.2AstraZeneca
- 11.2.1Business Overview
- 11.2.2Financial Snapshot
- 11.2.3Products and Services
- 11.2.4Recent Developments
- 11.3Caribou Biosciences, Inc.
- 11.3.1Business Overview
- 11.3.2Financial Snapshot
- 11.3.3Products and Services
- 11.3.4Recent Developments
- 11.4Cellectis
- 11.4.1Business Overview
- 11.4.2Financial Snapshot
- 11.4.3Products and Services
- 11.4.4Recent Developments
- 11.5CRISPR Therapeutics
- 11.5.1Business Overview
- 11.5.2Financial Snapshot
- 11.5.3Products and Services
- 11.5.4Recent Developments
- 11.6Danaher Corporation
- 11.6.1Business Overview
- 11.6.2Financial Snapshot
- 11.6.3Products and Services
- 11.6.4Recent Developments
- 11.7Editas Medicine, Inc.
- 11.7.1Business Overview
- 11.7.2Financial Snapshot
- 11.7.3Products and Services
- 11.8Horizon Discovery Group Plc
- 11.8.1Business Overview
- 11.8.2Financial Snapshot
- 11.8.3Products and Services
- 11.8.4Recent Developments
- 11.9Mammoth Biosciences
- 11.9.1Business Overview
- 11.9.2Financial Snapshot
- 11.9.3Products and Services
- 11.10New England BioLabs
- 11.10.1Business Overview
- 11.10.2Financial Snapshot
- 11.10.3Products and Services
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.